140 related articles for article (PubMed ID: 37616492)
1. The preanalytical stability of emerging cannabinoid analogs (delta-8 THC and its metabolites, delta-10 THC and carboxy-HHC) in urine.
Pokhai AA; Poklis JL; Williams GR; Wolf CE
J Anal Toxicol; 2023 Nov; 47(8):726-731. PubMed ID: 37616492
[TBL] [Abstract][Full Text] [Related]
2. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays.
Wolf CE; Pokhai AA; Poklis JL; Williams GR
J Anal Toxicol; 2023 Nov; 47(8):732-736. PubMed ID: 37602947
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
Fraser AD; Worth D
Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of ∆8-tetrahydrocannabinol carboxylic acid in workplace drug testing.
Vikingsson S; Hart ED; Winecker RE; Cone EJ; Kuntz DJ; Clark M; Jacques M; Hayes ED; Flegel RR
J Anal Toxicol; 2023 Nov; 47(8):719-725. PubMed ID: 37697897
[TBL] [Abstract][Full Text] [Related]
5. Quantification of (9R)- and (9S)-hexahydrocannabinol (HHC) via GC-MS in serum/plasma samples from drivers suspected of cannabis consumption and immunological detection of HHC and related substances in serum, urine, and saliva.
Höfert L; Becker S; Dreßler J; Baumann S
Drug Test Anal; 2024 May; 16(5):489-497. PubMed ID: 37652872
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of CBD, Δ
Jaidee W; Siridechakorn I; Nessopa S; Wisuitiprot V; Chaiwangrach N; Ingkaninan K; Waranuch N
Cannabis Cannabinoid Res; 2022 Aug; 7(4):537-547. PubMed ID: 34096805
[No Abstract] [Full Text] [Related]
7. Chemical transformation of cannabidiol into psychotropic cannabinoids under acidic reaction conditions: Identification of transformed products by GC-MS.
Jeong M; Lee S; Seo C; Kwon E; Rho S; Cho M; Kim MY; Lee W; Lee YS; Hong J
J Food Drug Anal; 2023 Mar; 31(1):165-176. PubMed ID: 37224558
[TBL] [Abstract][Full Text] [Related]
8. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review.
Ujváry I
Drug Test Anal; 2024 Feb; 16(2):127-161. PubMed ID: 37269160
[TBL] [Abstract][Full Text] [Related]
9. Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC-HRMS-MS.
Manier SK; Valdiviezo JA; Vollmer AC; Eckstein N; Meyer MR
J Anal Toxicol; 2023 Dec; 47(9):818-825. PubMed ID: 37864499
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens.
Vikingsson S; Winecker RE; Cone EJ; Kuntz DJ; Dorsey B; Jacques M; Senter M; Flegel RR; Hayes ED
J Anal Toxicol; 2022 Oct; 46(8):866-874. PubMed ID: 35260906
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
Fraser AD; Worth D
Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
[TBL] [Abstract][Full Text] [Related]
12. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
[TBL] [Abstract][Full Text] [Related]
13. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina.
Fernández N; Cappello MG; Quiroga PN
Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612
[TBL] [Abstract][Full Text] [Related]
14. The effect of antioxidants on the long-term stability of THC and related cannabinoids in sampled whole blood.
Sørensen LK; Hasselstrøm JB
Drug Test Anal; 2018 Feb; 10(2):301-309. PubMed ID: 28570781
[TBL] [Abstract][Full Text] [Related]
15. LC-MS/MS analysis of 11-nor-9-carboxy-hexahydrocannabinol (HHC-COOH) and 11-hydroxy-hexahydrocannabinol (HHC-OH) for verification of hexahydrocannabinol (HHC) intake.
Pettersson-Pablo P; Oxelbark J
Scand J Clin Lab Invest; 2024 Apr; 84(2):109-114. PubMed ID: 38529884
[TBL] [Abstract][Full Text] [Related]
16. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
[TBL] [Abstract][Full Text] [Related]
17. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
Fraser AD; Worth D
Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs.
Janssens LK; Van Uytfanghe K; Williams JB; Hering KW; Iula DM; Stove CP
Arch Toxicol; 2024 May; ():. PubMed ID: 38735004
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids in Oral Fluid: Limiting Potential Sources of Cannabidiol Conversion to Δ9- and Δ8-Tetrahydrocannabinol.
Coulter C; Wagner JR
J Anal Toxicol; 2021 Sep; 45(8):807-812. PubMed ID: 34137890
[TBL] [Abstract][Full Text] [Related]
20. Re-Examining Cannabidiol: Conversion to Tetrahydrocannabinol Using Only Heat.
Daniels R; Yassin OA; Toribio JM; Gascón JA; Sotzing G
Cannabis Cannabinoid Res; 2024 Apr; 9(2):486-494. PubMed ID: 36516105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
